Servier

Servier is one of the leading European pharmaceutical companies in Russia. In 2022, the company celebrated 30 years of operation in Russia. Today, more than 1500 employees work at the Russian branch of the company. The company's medicines are included in current treatment recommendations and standards, as well as in the list of essential medicines. In its daily activities, Servier adheres to the principles of responsible and ethical business practices, based on openness, transparency, and compliance with all legal norms and regulations.\n\nIn 1999, the Servier Research and Development Center was established in Russia, which has successfully collaborated for over 20 years with leading research institutes, federal medical centers, and educational and healthcare institutions in the field of preclinical and clinical development of new drugs. Over the years, more than 100 clinical studies have been conducted in 40 cities in Russia, involving more than 20,000 patients.\n\nFor Servier, corporate social responsibility is an integral part of its long-term sustainable development strategy. The principles of social responsibility are organically integrated into all aspects of the company's operations and are applied in its relationships with the surrounding world.